Four Peaks Healthcare Associates

11/15/2025

How is a weight loss medication helping people with ME/CFS and Long Covid? When Zepbound was studied there was evidence of other benefits beyond weight loss and it appears to be a strong anti-inflammatory drug also.

GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid.

11/04/2025

Science Daily reports on the newly discovered way to identify MECFS through DNA folds. Researchers state, "Our discovery offers the potential for a simple, accurate blood test to help confirm a diagnosis, which could lead to earlier support and more effective management."

A team of scientists has developed a highly accurate blood test for Chronic Fatigue Syndrome. The test reads tiny DNA patterns that reveal the biological signature of the illness. For millions who’ve faced doubt and misdiagnosis, it’s a breakthrough that finally validates their experience — an...

10/28/2025

The use of Oxaloacetate to treat "fatigue, cognitive function, and daily activity in people with ME/CFS, and what it reveals about how supporting cellular energy metabolism may help improve both brain and body function." This blog gives you the "Deep Dive" into this treatment and its benefits.

A new clinical trial led by researchers at the Bateman Horne Center (BHC) offers encouraging evidence that targeting metabolism may help improve both brain function and daily activity in people with…

10/21/2025

Fibromyalgia (FM) and MECFS are showing up in genetic studies as a similar genetic architecture. The authors stated that these findings are "putting FM on a “firm biological foundation”".
Cort Johnson of Health Rising provides his summary or "the gist" section if the article is too long or complicated to read.

Geoff’s Narration The GIST   Just months after the publication of the first large ME/CFS GWAS study comes an enormous FM GWAS study. Notice how these two diseases seem to be marching hand in hand. Both are greatly underfunded, both are still struggling for recognition in some circles, symptoms de...

10/09/2025

It is nice to read about what is happening in the world of ME/CFS research. This is a long technical report regarding promising research in finding a diagnostic biomarker.
Since this is long and technical you may want to read the abstract and then the conclusion to manage the information.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating, multifactorial disorder characterised by profound fatigue, post-exertional malaise, cognitive impairments, and autonomic dysfunction. Despite its significant impact on quality of life, ME/CFS lacks definitive diagnostic b...

10/02/2025

This is a webinar designed for healthcare providers and also all Long COVID and ME/CFS patient-lived experience experts interested in learning more about the treatment of Long COVID and ME/CFS.

"The aim of the webinar-style program is to rapidly disseminate post-acute Sequelae of COVID-19 and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome findings and emerging best practices".

Link is included in information to register for this free webinar sponsored by multiple medical groups.

08/26/2025

Tonmya has finally been approved for the treatment of fibromyalgia.

"For over 15 years, this community has been underserved and waiting for new treatment options. This approval is a promising step forward and brings renewed hope to millions.”

Tonmya is the first FDA approved drug for use in fibromyalgia in 15 years. Seth Lederman, CEO of Tonix Pharmaceuticals, talked about how the drug was developed, what it does, and when it will become available.

08/11/2025

A large study out of Edinburgh identifies a common genetic link in ME/CFS. Although genetics does not explain ME/CFS in its entirety it does add a possible puzzle piece to what causes ME/CFS and other post-infectious diseases.

Chronic fatigue syndrome or myalgic encephalomyelitis (ME/CFS) is a debilitating and long-neglected disease that experts typically dismissed as psychosomatic for decades.

07/29/2025

An article updating research on ME/CFS. There is a short, 4 minute video for those that have trouble with the written word.

Chronic fatigue syndrome is characterized by dizziness, sleep problems, dizziness, chronic pain and fatigue. For years, clinicians debated... | Microbiology

07/29/2025

The CDC has released an update on Long Covid, nothing new from those who have ME/CFS or Long Covid. This article may be of help for those of you that have medical providers that are gaslighting you, don't believe you and your symptoms or just don't know the basic symptoms of Long Covid.

Some symptoms could be neurological, the CDC said.

07/24/2025

Scientists are finding an increased risk of ME/CFS after SARS-CoV-2 in people up to 4 years after their infection.

"Emerging evidence suggests that SARS-CoV-2 may also act as a trigger for CFS/ME, contributing to a broader constellation of symptoms now referred to as post-acute sequelae of SARS-CoV-2 infection or long-COVID."

Background Fatigue is a common sequela of SARS-CoV-2 infection, with many COVID-19 patients subsequently developing chronic fatigue syndrome and myalgic encephalomyelitis (CFS/ME). Long-term associations between COVID-19, new-onset CFS/ME, and other independent predictors such as vaccination for SAR...

07/12/2025

TREATME: Open Medicine's Mammoth ME/CFS and Long COVID Treatment Survey Results is summarized in Health Rising's latest blog. There is good information about what is and isn't working in the treatment of ME/CFS and Long Covid.

The massive TreatME survey assessed the effectiveness of 150 treatments in ME/CFS and long COVID.